Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000249006 is a human pseudogene named "Pseudogene similar to part of HBS1-like," identified by sequence homology to the protein-coding HBS1L (HBS1 like translational GTPase) gene. Pseudogenes are segments of DNA resembling genes but are generally nonfunctional and incapable of producing functional proteins due to disabling mutations or lack of essential regulatory elements. This pseudogene is classified as either a processed or duplicated pseudogene, based on its biogenesis and resemblance to the parent gene. Pseudogenes are not considered therapeutic targets and do not act as receptors, enzymes, or transporters. There is no evidence for direct involvement in disease, drug interactions, or use as biomarkers. Annotation of pseudogenes like ENSG00000249006 in genetic databases serves primarily to clarify genomic structure and avoid confusion with functional genes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of HBS1-like (ENSG00000249006).